148 related articles for article (PubMed ID: 22959509)
1. MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma.
Gao X; Zhang R; Qu X; Zhao M; Zhang S; Wu H; Jianyong L; Chen L
Leuk Res; 2012 Dec; 36(12):1505-9. PubMed ID: 22959509
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
[TBL] [Abstract][Full Text] [Related]
3. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
Sewastianik T; Straubhaar JR; Zhao JJ; Samur MK; Adler K; Tanton HE; Shanmugam V; Nadeem O; Dennis PS; Pillai V; Wang J; Jiang M; Lin J; Huang Y; Brooks D; Bouxsein M; Dorfman DM; Pinkus GS; Robbiani DF; Ghobrial IM; Budnik B; Jarolim P; Munshi NC; Anderson KC; Carrasco RD
Blood; 2021 Apr; 137(14):1905-1919. PubMed ID: 33751108
[TBL] [Abstract][Full Text] [Related]
4. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
de Groen FL; Timmer LM; Menezes RX; Diosdado B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
PLoS One; 2015; 10(7):e0132495. PubMed ID: 26148070
[TBL] [Abstract][Full Text] [Related]
6. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
7. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
[TBL] [Abstract][Full Text] [Related]
8. Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma.
Corthals SL; Jongen-Lavrencic M; de Knegt Y; Peeters JK; Beverloo HB; Lokhorst HM; Sonneveld P
Leuk Res; 2010 May; 34(5):677-81. PubMed ID: 20031211
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.
Li F; Xu Y; Deng P; Yang Y; Sui W; Jin F; Hao M; Li Z; Zang M; Zhou D; Gu Z; Ru K; Wang J; Cheng T; Qiu L
Oncotarget; 2015 Apr; 6(11):9434-44. PubMed ID: 25831238
[TBL] [Abstract][Full Text] [Related]
10. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity.
Xiao G; Li Y; Wang Y; Zhao B; Zou Z; Hou S; Jia X; Liu X; Yao Y; Wan J; Xiong H
Exp Cell Res; 2018 Sep; 370(2):254-263. PubMed ID: 29944867
[TBL] [Abstract][Full Text] [Related]
12. [Expression level of microRNA-92a and its clinical significance in multiple myeloma patients].
Qu XY; Zhang SS; Wu S; Hong M; Li JY; Chen LJ; Xu JR
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):332-6. PubMed ID: 23668207
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
[TBL] [Abstract][Full Text] [Related]
14. MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.
Li Y; Zhang B; Li W; Wang L; Yan Z; Li H; Yao Y; Yao R; Xu K; Li Z
Leuk Res; 2016 Oct; 49():73-9. PubMed ID: 27596960
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China.
Wang H; Meng H; Wang J; Lou Y; Zhou Y; Lin P; Li F; Liu L; Xu H; Yang M; Jin J
Front Med; 2020 Jun; 14(3):327-334. PubMed ID: 31784918
[TBL] [Abstract][Full Text] [Related]
17. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma.
Li F; Hao M; Feng X; Zang M; Qin Y; Yi S; Li Z; Xu Y; Zhou L; Sui W; Deng S; Zou D; Zhan F; Qiu L
Leuk Res; 2015 Jul; 39(7):793-9. PubMed ID: 25975752
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.
Huang JJ; Yu J; Li JY; Liu YT; Zhong RQ
Med Oncol; 2012 Dec; 29(4):2402-8. PubMed ID: 22447484
[TBL] [Abstract][Full Text] [Related]
19. Signal pathways, diseases, and functions associated with the miR-19a/92a cluster and the use of berberine to modulate the expression of this cluster in multiple myeloma cells.
Yin Z; Yang J; Ning R; Liu Y; Feng M; Gu C; Fei J; Li Y
J Biochem Mol Toxicol; 2018 Jun; 32(6):e22057. PubMed ID: 29687521
[TBL] [Abstract][Full Text] [Related]
20. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.
Braoudaki M; Lambrou GI; Giannikou K; Papadodima SA; Lykoudi A; Stefanaki K; Sfakianos G; Kolialexi A; Tzortzatou-Stathopoulou F; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
Tumour Biol; 2016 Jul; 37(7):9887-97. PubMed ID: 26813564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
